PLURISTEM THERAPEUTICS INC Contracts & Agreements

Amended and Restated Consulting Agreement by and between Pluri Biotech Ltd. and Mr. Zalman (Zami) Aberman, dated February 13, 2023 (Filed With SEC on February 13, 2023)

Form of Warrant (Filed With SEC on December 19, 2022)

Form of Securities Purchase Agreement (Filed With SEC on December 19, 2022)

Share Purchase Agreement, dated January 5, 2022, by and among Tnuva Food-Tech Incubator (2019), Limited Partnership, Plurinuva Ltd. and Pluristem Ltd (Filed With SEC on May 9, 2022)

Technology License Agreement, dated January 5, 2022, by and between Pluristem Ltd. and Plurinuva Ltd (Filed With SEC on May 9, 2022)

Summary of Supplement to the Lease Agreement by and between Pluristem Ltd. and MTM Scientific Industries Center Haifa Ltd dated December 31, 2021 (Filed With SEC on February 7, 2022)

Consulting Agreement by and between Pluristem Ltd. and Mr. Zalman (Zami) Aberman, dated January 1, 2022 (Filed With SEC on January 3, 2022)

Form of Restricted Stock Unit Agreement (executive officers) under the 2019 Equity Compensation Plan (Filed With SEC on September 13, 2021)

Form of Restricted Stock Unit Agreement (directors) under the 2019 Equity Compensation Plan (Filed With SEC on September 13, 2021)

Form of Restricted Stock Unit Agreement (employees) under the 2019 Equity Compensation Plan (Filed With SEC on September 13, 2021)

Letter agreement by and between Pluristem Ltd. and Rose High Tech Ltd., dated September 13, 2021 (Filed With SEC on September 13, 2021)

Letter agreement by and between Pluristem Ltd. and Yaky Yanay, dated September 13, 2021 (Filed With SEC on September 13, 2021)

Letter agreement by and between Pluristem Ltd. and Chen Franco-Yehuda, dated September 13, 2021 (Filed With SEC on September 13, 2021)

Form of Director and Officer Indemnification Agreement (Filed With SEC on February 8, 2021)

Form of Securities Purchase Agreement, dated February 2, 2021, among Pluristem Therapeutics Inc. and the Purchasers named therein (Filed With SEC on February 3, 2021)

Placement Agency Agreement, dated February 2, 2021, between Pluristem Therapeutics Inc. and A.G.P./Alliance Global Partners (Filed With SEC on February 3, 2021)

Guarantee Agreement by and among the European Investment Bank, Pluristem Therapeutics, Inc. and Pluristem GmbH, dated September 30, 2020 (Filed With SEC on November 5, 2020)

Guarantee Agreement by and among the European Investment Bank, Pluristem Ltd. and Pluristem GmbH dated, September 30, 2020 (Filed With SEC on November 5, 2020)

Description of Securities (Filed With SEC on September 10, 2020)

Summary of Directors Ongoing Compensation (Filed With SEC on September 10, 2020)

Amended and Restated Consulting Agreement between Pluristem Ltd. and Rose High Tech Ltd. dated September 10, 2020 (Filed With SEC on September 10, 2020)

Amended and Restated Employment Agreement between Pluristem Ltd. and Yaky Yanay dated September 10, 2020 (Filed With SEC on September 10, 2020)

Amended and Restated Employment Agreement between Pluristem Ltd. and Chen Franco-Yehuda dated September 10, 2020 (Filed With SEC on September 10, 2020)

Finance Contract between the European Investment Bank, as Lender, and Pluristem GmBH, as borrower, and Pluristem Therapeutics Inc. and Pluristem Ltd., as Original Guarantors,... (Filed With SEC on September 10, 2020)

Form of Securities Purchase Agreement (Filed With SEC on May 5, 2020)

Description of Securities (Filed With SEC on September 12, 2019)

Summary of Directors Ongoing Compensation (Filed With SEC on September 12, 2019)

Form of Stock Option Agreement under the 2019 Equity Compensation Plan (Filed With SEC on September 12, 2019)

orm of Restricted Stock Agreement under the 2019 Equity Compensation Plan (Filed With SEC on September 12, 2019)

Form of Restricted Stock Agreement (Israeli directors and officers) under the 2019 Equity Compensation Plan (Filed With SEC on September 12, 2019)

Warrant Agreement by and between Pluristem Therapeutics Inc. and American Stock Transfer & Trust Company, LLC (including the form of Warrant certificate) (Filed With SEC on May 6, 2019)

Underwriting Agreement, dated April 4, 2019, between Pluristem Therapeutics Inc. and Ladenburg Thalmann & Co. Inc., as representative of the underwriters named therein (Filed With SEC on May 6, 2019)

Subscription Agreement, dated April 4, 2019, between Pluristem Therapeutics Inc. and ARK Genomic Revolution ETF (Filed With SEC on May 6, 2019)

Employment Agreement between Pluristem Ltd. and Chen Franco-Yehuda dated May 6, 2019 (Filed With SEC on May 6, 2019)

Underwriting Agreement, dated April 4, 2019, between Pluristem Therapeutics Inc. and Ladenburg Thalmann & Co. Inc., as representative of the underwriters named therein (Filed With SEC on April 5, 2019)

Form of Warrant Agreement by and between Pluristem Therapeutics Inc. and American Stock Transfer & Trust Company, LLC (including the form of Warrant certificate) (Filed With SEC on April 5, 2019)

Form of Subscription Agreement (Filed With SEC on April 5, 2019)

Open Market Sale AgreementSM, dated February 6, 2019, by and between the Company and Jefferies LLC (Filed With SEC on February 6, 2019)

Consulting Agreement between Pluristem Ltd. and Rose High Tech Ltd. dated September 12, 2018 (Filed With SEC on September 12, 2018)

Employment Agreement between Pluristem Ltd. and Yaky Yanay dated September 12, 2018 (Filed With SEC on September 12, 2018)

Employment Agreement between Pluristem Ltd. and Erez Egozi dated September 12, 2018 (Filed With SEC on September 12, 2018)

Engagement Letter dated October 29, 2017, between Pluristem Therapeutics Inc. and Leader Underwriters (1993) Ltd (Filed With SEC on October 30, 2017)

Amendment No. 2 to Binding Term Sheet by and between Pluristem Therapeutics Inc. and Sosei Corporate Venture Capital Ltd., dated August 15, 2017 (English version only) (Filed With SEC on September 7, 2017)

Amendment to Consulting Agreement between Pluristem Ltd. and Rose High Tech Ltd. dated May 5, 2017 (Filed With SEC on September 7, 2017)

PLURISTEM THERAPEUTICS INC. Common Stock (par value $0.00001 per share) At Market Issuance Sales Agreement (Filed With SEC on July 7, 2017)

Pluristem Ltd. (Filed With SEC on May 8, 2017)

TERM SHEET October 25, 2016 (Filed With SEC on February 8, 2017)

TERM SHEET BY AND BETWEEN PLURISTEM LTD. AND SOSEI CORPORATE VENTURE CAPITAL LTD. WITH RESPECT TO ESTABLISHMENT AND OPERATION OF A JOINT VENTURE December 19, 2016 (Filed With SEC on February 8, 2017)

8,163,265 Shares and Warrants to purchase 4,897,959 Shares PLURISTEM THERAPEUTICS INC. UNDERWRITING AGREEMENT (Filed With SEC on January 20, 2017)

Execution Version 12,244,898 Shares and Warrants to purchase 7,346,939 Shares PLURISTEM THERAPEUTICS INC. AMENDED AND RESTATED UNDERWRITING AGREEMENT (Filed With SEC on January 20, 2017)

COMMON STOCK PURCHASE WARRANT PLURISTEM THERAPEUTICS INC. (Filed With SEC on January 20, 2017)

Pluristem Therapeutics Inc. STOCK OPTION AGREEMENT Made as of the _______________ (Filed With SEC on September 7, 2016)

Pluristem Therapeutics Inc. RESTRICTED STOCK AGREEMENT Made as of the _____________________________ (Filed With SEC on September 7, 2016)

Pluristem Therapeutics Inc. RESTRICTED STOCK AGREEMENT Made as of the __________________ (Filed With SEC on September 7, 2016)

The National Authority for Technological Innovation (Filed With SEC on September 7, 2016)

State of Israel Ministry of Economy Industrial Research and Development Administration Office of Chief Scientist (Filed With SEC on September 9, 2015)

[The remainder of this page has been intentionally left blank.] (Filed With SEC on June 25, 2015)

COMMON STOCK PURCHASE WARRANT PLURISTEM THERAPEUTICS, INC. Warrant Shares: _______Initial Exercise Date: June __, 2015 (Filed With SEC on June 25, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 25, 2015)

State of Israel Ministry of Trade and Industry Industrial Research and Development Administration Office of Chief Scientist (Filed With SEC on September 11, 2014)

State of Israel Ministry of Economy Industrial Research and Development Administration Office of Chief Scientist (Filed With SEC on September 11, 2014)

EXCLUSIVE LICENSE AND COMMERCIALIZATION AGREEMENT (Filed With SEC on September 11, 2013)

WARRANT AGREEMENT (Filed With SEC on November 6, 2012)

WARRANT AGREEMENT (Filed With SEC on September 19, 2012)

8,000,000 Shares and Warrants to purchase 2,800,000 Shares PLURISTEM THERAPEUTICS INC. UNDERWRITING AGREEMENT (Filed With SEC on September 14, 2012)

WARRANT AGREEMENT (Filed With SEC on September 14, 2012)

WARRANT AGREEMENT (Filed With SEC on January 27, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 12, 2010)

PLURISTEM THERAPEUTICS INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on April 28, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 28, 2010)

- 2 - (Filed With SEC on October 6, 2009)

ARTICLE I. DEFINITIONS (Filed With SEC on October 6, 2009)

- 2 - (Filed With SEC on September 23, 2009)

Pluristem Therapeutics Inc. RESTRICTED STOCK AGREEMENT Made as of the __________________ (Filed With SEC on September 23, 2009)

Summary of Directors Ongoing Compensation (Filed With SEC on May 11, 2009)

Page 2 (Filed With SEC on May 6, 2009)

ARTICLE I. DEFINITIONS (Filed With SEC on May 6, 2009)

- 1 - (Filed With SEC on February 3, 2009)

- 1 - (Filed With SEC on December 3, 2008)

- 1 - (Filed With SEC on September 23, 2008)

Page 2 (Filed With SEC on August 6, 2008)